IP Library Granted Patent US 9,534,257
Granted Patent B2
US 9,534,257 · App. 14/099,827 · Granted Jan 3, 2017

Multiplex nucleic acid detection methods and systems

Inventor: Timothy Z. Liu (Fremont, CA)
Assignee: LIFEOS GENOMICS CORPORATION
C12Q1/6886C12Q1/6844
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,534,257
App. No.
14/099,827
Granted
Jan 3, 2017
Kind
B2
Abstract

The present invention relates to methods and systems for single molecule based nucleic acid amplification and subsequent detection of nucleic acid molecules, and particularly to the determination of SNPs, mutations, and to the diagnosis of diseases associated with the changes of these nucleic acid molecules.

Claims (26)

1. A method of identifying target nucleic acid sequences in a sample, comprising:

(a) generating from a sample a plurality of first template molecules and a plurality of second template molecules, wherein said first template molecules comprise a sequence of a first target nucleic acid and a first identity sequence (IS) tag, and said second template molecules comprise a sequence of a second target nucleic acid and a second IS tag, and wherein said first IS tag comprises a first identification (ID) code and said second IS tag comprises a second ID code;

(b) generating at least one cluster of nucleic acid amplicons by nucleic acid amplification of said first template molecules and at least one cluster of nucleic acid amplicons by clonal amplification of said second template molecules in parallel individual reactions on a surface, wherein said clusters of nucleic acid amplicons are spatially separated; and

(c) identifying said ID codes of said IS tags of said nucleic acid amplicons on said surface to determine the target nucleic acid sequences represented by said nucleic acid amplicons and the step (c) of identifying said ID codes of said IS tags of said nucleic acid amplicons further comprises:

(c-1) hybridizing a pair of labeled IS probes (LISPs) from a pool of LISPs with said clusters of nucleic acid amplicons, thereby said pair of LISPs are juxtaposed, wherein each said LISP comprises: (i) a sequence complimentary to the IS tag sequence it hybridizes to, and (ii) a detectable label associated with a designated base at base interrogation positions, and wherein there are two sets of the LISPs in each pool of LISPs, with one set being the 3′ labeled IS probes (3′-LISPs) that comprise 5′ phosphate groups and 3′ detectable labels, and the other set being the 5′ labeled IS probes (5′-LISPs) that comprise 5′ detectable labels and 3′ hydroxyl groups;

(c-2) performing a paired-probe ligation of said pair of juxtaposed LISPs;

(c-3) detecting the presence of said detectable labels on said ligated pair of LISPs on said IS tags of said nucleic acid amplicons, and elucidating the base composition at said base interrogation positions of said IS tags according to the detectable label combination of said ligated pair of LISPs, wherein two specified base positions on said IS tags and one on each side of said paired probes are interrogated;

(c-4) denaturing said ligated pair of LISPs from said analyte molecule;

(c-5) repeating steps (c-1) to (c-4) until all bases of base interrogation positions in said IS tags are interrogated without duplication and all base composition of said IS tags are elucidated; and

(c-6) determining the ID codes of said IS tags on said nucleic acid amplicons by comparing said base composition to designated ID codes, wherein 10^n (or 10 n ) kinds of the base combinations are distinguished in n times of the paired-probe ligation.

2. The method of claim 1 , wherein the position of each cluster of nucleic acid amplicons is kept fixed relative to other clusters on the surface during said nucleic acid sequence analysis.

3. The method of claim 1 , further comprising determining the sequence variations of said target nucleic acid sequences by analyzing the sequence variations of said clusters of said nucleic acid amplicons on said surface.

4. The method of claim 1 , wherein said first and second target nucleic acid sequences can be the same or different; and there can be more than said first and second target nucleic acid sequences.

5. The method of claim 1 , further comprising quantifying the number of clusters of nucleic acid amplicons from said template molecules to infer the amount of each target nucleic acid sequence in said sample.

6. The method of claim 1 , wherein said spatially separated clusters of nucleic acid amplicons are generated on said surface through enzymatic amplification or replication, and at least one of the primers used in said amplification or replication is attached to said surface during said nucleic acid amplification.

7. The method of claim 1 , wherein each said cluster of nucleic acid amplicons is generated on a solid support on said surface through enzymatic amplification or replication, and at least one of the primers used in said amplification or replication is attached to said solid support on said surface during said nucleic acid amplification.

8. The method of claim 1 , wherein said parallel individual reactions are carried out in a plurality of individual aqueous droplets on a surface, wherein each droplet comprises reagents for nucleic acid amplification or replication, including a plurality of primers.

9. The method of claim 8 , wherein said individual aqueous droplets are formed by water-in-oil emulsion on said surface, and an oil phase of said water-in-oil emulsion comprises a water immiscible liquid.

10. The method of claim 8 , wherein said nucleic acid amplification or replication of template molecules is carried out in hydrophilic reaction sites surrounded by a hydrophobic surface, wherein each hydrophilic reaction site comprises a said individual aqueous droplet.

11. The method of claim 8 , wherein said DNA amplification is polymerase chain reaction (PCR), and said surface is thermal cycled during said nucleic acid amplification.

12. The method of claim 8 , wherein said nucleic acid amplification or replication is carried out through circularization of single stranded template molecules and subsequent isothermal rolling circle amplification by a DNA polymerase, on extension oligonucleotides attached at 5′ ends on said surface, and said extension oligonucleotides are complementary at 3′ ends to the circularized template molecules and comprise free 3′ —OH groups for enzymatic extension.

13. The method of claim 8 , wherein some of the said individual aqueous droplets further comprise at least one microparticle comprising at least one of said primers attached on surface.

14. The method of claim 13 , wherein nucleic acid amplicons are generated on the surface of magnetic microparticles; and said magnetic microparticles are immobilized on said surface by a physical force or by a chemical linkage.

15. The method of claim 1 , wherein there are four different detectable labels on the two sets of the LISPs with each detectable label representing a designated base (A, C, G, T) at base interrogation positions, and wherein all probes needed for all possible base combinations at said base interrogation positions are included in each pool of LISPs.

16. The method of claim 1 , wherein a different pool of LISPs is used in each ligation cycle, and wherein different base positions on said IS tags are sequentially interrogated in each ligation cycle.

17. The method of claim 1 , wherein the labels on said LISP comprises fluorescent dyes, electrochemical labels, or nanoparticles.

Assignments (3)
SECURITY INTEREST Recorded Dec 27, 2023
From: LIFEOS GENOMICS CORPORATION
To: TAI, LI-MEI
Reel/Frame 065965/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2020
From: LIFEOS GENOMICS CORPORATION
To: LIFEOS GENOMICS CORPORATION
Reel/Frame 051550/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2015
From: LIU, TIMOTHY Z.
To: LIFEOS GENOMICS CORPORATION
Reel/Frame 035394/0473 →
Continuity (7)
Division 13252095 · Oct 3, 2011
Continuation PCTUS2010029777 · Apr 2, 2010
Provisional Application 61166479 · Apr 3, 2009
Provisional Application 61166553 · Apr 3, 2009
Provisional Application 61172660 · Apr 24, 2009
Provisional Application 61266037 · Dec 2, 2009
Related Publication 20140093876A1 · Apr 3, 2014